Sept 20 (Reuters) - Sirtex Medical Ltd :Richard Hill to retire as chairman at upcoming AGM.Richard hill has informed that he intends to retire from his role as independent chairman & non-executive director of company.John Eady will assume role of interim chairman until new chairman is appointed.
Sept 19 (Reuters) - OncoMed Pharmaceuticals Inc -:OncoMed chairman and CEO, Paul Hastings, to take medical leave of absence.OncoMed Pharmaceuticals Inc - Hastings will continue to be chief executive officer and chairman of board of directors during his leave of absence.OncoMed Pharmaceuticals Inc - in Hastings' absence, co will be led by company's senior management team including creation of an office of president.
Sept 19 (Reuters) - Edge Therapeutics Inc :Edge Therapeutics appoints Rosemary A Crane, pharmaceutical industry leader, to its Board Of Directors.Edge Therapeutics Inc - Crane's appointment expands Board of Directors to 10 members, eight of whom are independent.Edge Therapeutics Inc - Crane currently serves as a Director of Teva Pharmaceuticals and as vice chairman of Board of Zealand Pharma A/S.
Sept 18 (Reuters) - Bioasis Technologies Inc :BIOASIS ANNOUNCES ROB HUTCHISON, FOUNDER, TO RETIRE AS CHAIRMAN & BOARD MEMBER.BIOASIS TECHNOLOGIES INC - MICHAEL HUTCHISON WILL ALSO STEP DOWN FROM BIOASIS BOARD IN OCTOBER 2017.BIOASIS TECHNOLOGIES INC - COMPANY IS ACTIVELY SEEKING TO HIRE A CHIEF FINANCIAL OFFICER.
Sept 15 (Reuters) - PLEDPHARMA AB (PUBL) ::PLEDPHARMA’S CFO TO LEAVE THE COMPANY IN DECEMBER 2017.SHE WILL LEAVE HER POSITION IN DECEMBER 2017.MICHAELA GERTZ HAS DECIDED TO LEAVE COMPANY AFTER SEVEN YEARS AS CHIEF FINANCIAL OFFICER.
Sept 15 (Reuters) - Novita Healthcare Ltd :Bruce Higgins agreed to become chairman when Iain Kirkwood steps down from his role as executive chairman following 2017 AGM.
Sept 14 (Reuters) - SHIELD THERAPEUTICS PLC :SAYS JOANNE ESTELL, HAS RESIGNED HER BOARD POSITION AND AS CHIEF FINANCIAL OFFICER AND COMPANY SECRETARY.BOARD HAS APPOINTED DR KARL KEEGAN AS INTERIM CHIEF FINANCIAL OFFICER WITH IMMEDIATE EFFECT.
Sept 14 (Reuters) - VALBIOTIS SAS ::VALBIOTIS: PASCAL SIRVENT APPOINTED DIRECTOR OF DISCOVERY AND PRECLINICAL RESEARCH.
Sept 13 (Reuters) - Keryx Biopharmaceuticals Inc ::KERYX BIOPHARMACEUTICALS ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS.SAYS MICHAEL ROGERS APPOINTED CHAIRMAN OF THE BOARD.KERYX BIOPHARMACEUTICALS INC- MICHAEL ROGERS SUCCEEDS JOHN BUTLER WHO HAS RESIGNED FROM KERYX'S BOARD.
Sept 13 (Reuters) - Amarin Corporation Plc :Amarin appoints Mark W. Salyer to new position of chief commercial officer.Amarin remains on track to reach record product revenues of $165 to $175 million in 2017.Most recently, Salyer was at Teva Pharmaceuticals as executive vice president and general manager of Teva Respiratory LLC.